1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 80, n° 6
pages 1782-1784 (juin 2019)
Doi : 10.1016/j.jaad.2018.12.021
Research Letters

Optimal concentration range of ustekinumab in patients with plaque-type psoriasis

Sergio Martín-González, PhD a, b, Peru Urigoitia-Ugalde, MD c, Jesús Careaga, MD c, Daniel Nagore, PhD b, Rosaura Navarro, PhD a, Rosa Izu-Belloso, MD c, Laura Blanch, MD c, Jaime González del Tánago, MD c, Antonio Martínez, PhD b, Ainhoa Ruiz del Agua, PhD b,
a Department of Physiology, Faculty of Medicine and Nursery, University of the Basque Country, Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Leioa, Spain 
b R&D Department, Progenika, Derio, Spain 
c Department of Dermatology, Basurto University Hospital, Bilbao, Spain 

Correspondence to: Ainhoa Ruiz del Agua, PhD, Parque Tecnologico Bizkaia 508, Progenika, Derio 48160, SpainParque Tecnologico Bizkaia 508, ProgenikaDerio48160Spain

 Funding sources: Dr Martín-González is supported by a Zabalduz predoctoral grant from Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Spain.
 Disclosure: Dr Ruiz del Agua and Dr Nagore are full-time employees of Progenika Biopharma. Dr Izu-Belloso has conducted clinical trials or received honoraria for serving as a consultant for Pfizer Pharmaceuticals, AbbVie, Janssen-Cilag Pharmaceutical, Novartis Pharmaceuticals, Celgene, and Eli Lilly and Company. Dr Urigoitia-Ugalde has conducted clinical trials for Janssen-Cilag Pharmaceutical and Novartis Pharmaceuticals. Dr Blanch has conducted clinical trials for Novartis Pharmaceuticals. Dr Martín-González, Dr Careaga, Dr Navarro, and Dr González del Tánago have no conflicts of interest to disclose.
 Reprints not available from the authors.

Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline